Biotech Investor Adds Million as Krystal Biotech Revenue Rises
A major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
Identify key components to include in your diversification checklist, ensuring broad exposure, appropriate risk, and alignment with retirement timing.
18,835 articlesA major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
A prominent market analyst says Ethereum may be near a bottom, even as Vitalik Buterin sells ETH. Traders are weighin...
With the 2026 midterms approaching, crypto markets face shifting liquidity and policy bets that could drive a notable...
President Trump directed federal agencies to end Anthropic's AI use, with a six-month phaseout for the Pentagon as a ...
Geopolitical tensions push markets lower as inflation and energy risk linger. This piece analyzes Coca-Cola as a cand...
REX Shares launches a new wave of ETF products focused on income, leverage, crypto, and thematic strategies to meet d...
Chime stock down since its June IPO has traders weighing risk and opportunity. A new $11 million stake from a promine...
Two tech titans sit on sale, but only one may fit a patient investor's plan. This guide breaks down the case for Micr...
On Tuesday, a leading critical metals stock surged on news before cooling later in the day. This piece explores what ...
This article lays out a grounded three-year path for Tesla, focusing on core EV leadership, software-based autonomy r...
Regulators have signaled close scrutiny of a possible Paramount-Warner Bros. merger, threatening delays and potential...
As the AI boom accelerates, the inference layer becomes the engine. This article explains why artificial intelligence...